Document Detail


Exposure to sibutramine during pregnancy.
MedLine Citation:
PMID:  17872638     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
QUESTION: One of my patients who was taking sibutramine to lose weight found out that she had unexpectedly conceived. The medication was stopped as soon as she found out, about 5 weeks into the pregnancy. Is the baby at risk? Should the pregnancy be aborted?
ANSWER: No data to date suggest that involuntary exposure to sibutramine during pregnancy carries major risk of congenital malformations. Nevertheless, this medication should be avoided whenever possible during pregnancy, as there is little information on its effects.
Authors:
Facundo Garcia-Bournissen; Alon Shrim; Gideon Koren
Related Documents :
12818438 - Live birth rate varies with gestational history and etiology in women experiencing recu...
10294678 - When rights collide.
8328238 - Papanicolaou smears in pregnancy. positivity of exfoliated cells for human chorionic go...
9225638 - Pregnancy termination--situation in finland.
20825588 - Incidence and prevention of early parturition in sows.
15925438 - Fetal head position during the second stage of labor: comparison of digital vaginal exa...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Canadian family physician Médecin de famille canadien     Volume:  53     ISSN:  1715-5258     ISO Abbreviation:  Can Fam Physician     Publication Date:  2007 Feb 
Date Detail:
Created Date:  2007-09-17     Completed Date:  2007-10-18     Revised Date:  2013-05-20    
Medline Journal Info:
Nlm Unique ID:  0120300     Medline TA:  Can Fam Physician     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  229-30     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antidepressive Agents / adverse effects,  therapeutic use*
Cohort Studies
Cyclobutanes / adverse effects,  therapeutic use*
Female
Humans
Infant, Newborn
Pregnancy
Pregnancy Complications / drug therapy*,  psychology
Pregnancy Outcome*
Pregnancy Trimester, First
Risk Assessment
Chemical
Reg. No./Substance:
0/Antidepressive Agents; 0/Cyclobutanes; WV5EC51866/sibutramine
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Why medical students switch careers: changing course during the preclinical years of medical school.
Next Document:  Uterine fibroid embolization: CME update for family physicians.